Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-dependent protein kinase activity	PRKDC ATM	1.02e-04	3	117	2	GO:0004677
GeneOntologyMolecularFunction	histone H2AXS139 kinase activity	PRKDC ATM	1.02e-04	3	117	2	GO:0035979
GeneOntologyMolecularFunction	histone H2AX kinase activity	PRKDC ATM	3.37e-04	5	117	2	GO:0141003
GeneOntologyMolecularFunction	G-protein beta/gamma-subunit complex binding	GNA12 PLCB2 GNAL	4.10e-04	25	117	3	GO:0031683
GeneOntologyMolecularFunction	lysine-acetylated histone binding	BRD3 BRD2 BRD4	7.09e-04	30	117	3	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	BRD3 BRD2 BRD4	7.82e-04	31	117	3	GO:0140033
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RGPD8 ITSN1 TBC1D7 ARFGEF1 GIT2 CAVIN4 RASGRP3 ITSN2 RGPD5 RGL4	8.04e-04	507	117	10	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RGPD8 ITSN1 TBC1D7 ARFGEF1 GIT2 CAVIN4 RASGRP3 ITSN2 RGPD5 RGL4	8.04e-04	507	117	10	GO:0030695
GeneOntologyBiologicalProcess	cell cycle process	CUL4B CUL1 PDS5B OFD1 RTEL1 POLE SPTBN1 KIF4A CIT NCAPG2 TLK1 NCAPG CCDC42 WASHC5 BRD4 SEPTIN14 DYNC1LI1 PDS5A PRKDC ATM TBX20 PMF1	1.53e-05	1441	116	22	GO:0022402
GeneOntologyBiologicalProcess	clathrin-dependent synaptic vesicle endocytosis	ITSN1 ITSN2	3.14e-05	2	116	2	GO:0150007
GeneOntologyBiologicalProcess	positive regulation of T-helper 17 cell differentiation	MALT1 BRD2 BRD4	6.03e-05	14	116	3	GO:2000321
GeneOntologyBiologicalProcess	chromosome segregation	OFD1 KIF4A CIT NCAPG2 TLK1 NCAPG WASHC5 BRD4 DYNC1LI1 ATM PMF1	6.37e-05	465	116	11	GO:0007059
Domain	ARM-type_fold	CEP104 PDS5B RELCH NBEAL1 MROH2A ARFGEF1 NCAPG2 ITPR2 NCAPG IPO9 INF2 PDS5A PRKDC ATM KPNA2	2.95e-09	339	116	15	IPR016024
Domain	HEAT_REPEAT	CEP104 PDS5B RELCH MROH2A NCAPG2 NCAPG PDS5A PRKDC	1.19e-08	70	116	8	PS50077
Domain	BET	BRD3 BRD2 BRD4	9.30e-07	4	116	3	PF17035
Domain	NET_dom	BRD3 BRD2 BRD4	9.30e-07	4	116	3	IPR027353
Domain	NET	BRD3 BRD2 BRD4	9.30e-07	4	116	3	PS51525
Domain	ARM-like	CEP104 PDS5B RELCH MROH2A ARFGEF1 NCAPG2 NCAPG IPO9 PDS5A PRKDC KPNA2	9.67e-07	270	116	11	IPR011989
Domain	-	CEP104 PDS5B RELCH ARFGEF1 NCAPG2 NCAPG IPO9 PDS5A PRKDC KPNA2	1.25e-06	222	116	10	1.25.10.10
Domain	Grip	RGPD8 GCC2 RGPD5	3.71e-05	11	116	3	SM00755
Domain	GRIP	RGPD8 GCC2 RGPD5	3.71e-05	11	116	3	PF01465
Domain	PH_13	ITSN1 ITSN2	3.82e-05	2	116	2	PF16652
Domain	GRIP_dom	RGPD8 GCC2 RGPD5	4.93e-05	12	116	3	IPR000237
Domain	GRIP	RGPD8 GCC2 RGPD5	4.93e-05	12	116	3	PS50913
Domain	HEAT	CEP104 NCAPG2 NCAPG PRKDC	2.23e-04	48	116	4	PF02985
Domain	PH_dom-like	RGPD8 NBEAL1 ITSN1 SPTBN1 CIT ITK AFAP1L1 ITSN2 PLCB2 RGPD5	3.25e-04	426	116	10	IPR011993
Domain	TPR-contain_dom	RGPD8 SRP72 TTC3 IFIT1B PRKDC RGPD5	3.49e-04	150	116	6	IPR013026
Domain	FATC	PRKDC ATM	3.78e-04	5	116	2	PF02260
Domain	HEAT	CEP104 NCAPG2 NCAPG PRKDC	4.63e-04	58	116	4	IPR000357
Domain	Bromodomain_CS	BRD3 BRD2 BRD4	5.47e-04	26	116	3	IPR018359
Domain	FAT	PRKDC ATM	5.64e-04	6	116	2	PS51189
Domain	FATC	PRKDC ATM	5.64e-04	6	116	2	PS51190
Domain	FAT	PRKDC ATM	5.64e-04	6	116	2	PF02259
Domain	PIK-rel_kinase_FAT	PRKDC ATM	5.64e-04	6	116	2	IPR003151
Domain	FATC_dom	PRKDC ATM	5.64e-04	6	116	2	IPR003152
Domain	PIK_FAT	PRKDC ATM	5.64e-04	6	116	2	IPR014009
Domain	FATC	PRKDC ATM	5.64e-04	6	116	2	SM01343
Domain	TPR_REGION	RGPD8 SRP72 TTC3 IFIT1B PRKDC RGPD5	5.78e-04	165	116	6	PS50293
Domain	TPR	RGPD8 SRP72 TTC3 IFIT1B PRKDC RGPD5	5.78e-04	165	116	6	PS50005
Domain	Cullin_CS	CUL4B CUL1	7.87e-04	7	116	2	IPR016157
Domain	Rab_bind	RGPD8 GCC2	7.87e-04	7	116	2	PF16704
Domain	CULLIN	CUL4B CUL1	7.87e-04	7	116	2	SM00182
Domain	GCC2_Rab_bind	RGPD8 GCC2	7.87e-04	7	116	2	IPR032023
Domain	Cullin_neddylation_domain	CUL4B CUL1	1.04e-03	8	116	2	IPR019559
Domain	Cullin_Nedd8	CUL4B CUL1	1.04e-03	8	116	2	PF10557
Domain	Cullin_Nedd8	CUL4B CUL1	1.04e-03	8	116	2	SM00884
Domain	Cullin_homology	CUL4B CUL1	1.34e-03	9	116	2	IPR016158
Domain	BROMODOMAIN_1	BRD3 BRD2 BRD4	1.56e-03	37	116	3	PS00633
Domain	Cullin	CUL4B CUL1	1.67e-03	10	116	2	PF00888
Domain	CULLIN_2	CUL4B CUL1	1.67e-03	10	116	2	PS50069
Domain	EF-hand_4	ITSN1 ITSN2	1.67e-03	10	116	2	PF12763
Domain	Cullin_N	CUL4B CUL1	1.67e-03	10	116	2	IPR001373
Domain	CULLIN_1	CUL4B CUL1	1.67e-03	10	116	2	PS01256
Domain	-	RGPD8 GCC2	1.67e-03	10	116	2	1.10.220.60
Domain	Bromodomain	BRD3 BRD2 BRD4	1.68e-03	38	116	3	PF00439
Domain	EH	ITSN1 ITSN2	2.03e-03	11	116	2	PS50031
Domain	EH	ITSN1 ITSN2	2.03e-03	11	116	2	SM00027
Domain	EH_dom	ITSN1 ITSN2	2.03e-03	11	116	2	IPR000261
Domain	BROMODOMAIN_2	BRD3 BRD2 BRD4	2.10e-03	41	116	3	PS50014
Domain	Bromodomain	BRD3 BRD2 BRD4	2.25e-03	42	116	3	IPR001487
Domain	BROMO	BRD3 BRD2 BRD4	2.25e-03	42	116	3	SM00297
Domain	-	BRD3 BRD2 BRD4	2.25e-03	42	116	3	1.20.920.10
Domain	TPR_1	RGPD8 SRP72 TTC3 RGPD5	2.39e-03	90	116	4	IPR001440
Domain	TPR_1	RGPD8 SRP72 TTC3 RGPD5	2.39e-03	90	116	4	PF00515
Domain	Ran_BP1	RGPD8 RGPD5	2.42e-03	12	116	2	PF00638
Domain	RANBD1	RGPD8 RGPD5	2.42e-03	12	116	2	PS50196
Domain	Cullin_repeat-like_dom	CUL4B CUL1	2.42e-03	12	116	2	IPR016159
Domain	-	ASTE1 FCF1	2.42e-03	12	116	2	3.40.50.1010
Domain	RanBD	RGPD8 RGPD5	2.85e-03	13	116	2	SM00160
Domain	Ran_bind_dom	RGPD8 RGPD5	2.85e-03	13	116	2	IPR000156
Domain	PH	ITSN1 SPTBN1 CIT ITK AFAP1L1 ITSN2	3.08e-03	229	116	6	PF00169
Domain	PIN_domain-like	ASTE1 FCF1	3.31e-03	14	116	2	IPR029060
Domain	TPR-like_helical_dom	RGPD8 SRP72 TTC3 IFIT1B PRKDC RGPD5	3.35e-03	233	116	6	IPR011990
Domain	PI3/4_kinase_CS	PRKDC ATM	3.81e-03	15	116	2	IPR018936
Domain	Spectrin_alpha_SH3	ITK ITSN2	3.81e-03	15	116	2	IPR013315
Domain	GproteinA_insert	GNA12 GNAL	4.34e-03	16	116	2	IPR011025
Domain	-	PRKDC ATM	4.34e-03	16	116	2	1.10.1070.11
Domain	-	GNA12 GNAL	4.34e-03	16	116	2	1.10.400.10
Domain	PI3Kc	PRKDC ATM	4.34e-03	16	116	2	SM00146
Domain	G-alpha	GNA12 GNAL	4.34e-03	16	116	2	PF00503
Domain	G_alpha	GNA12 GNAL	4.34e-03	16	116	2	SM00275
Domain	Gprotein_alpha_su	GNA12 GNAL	4.89e-03	17	116	2	IPR001019
Domain	PI3_PI4_kinase	PRKDC ATM	5.48e-03	18	116	2	PF00454
Domain	PI3_4_KINASE_1	PRKDC ATM	5.48e-03	18	116	2	PS00915
Domain	PI3_4_KINASE_2	PRKDC ATM	5.48e-03	18	116	2	PS00916
Domain	PI3/4_kinase_cat_dom	PRKDC ATM	5.48e-03	18	116	2	IPR000403
Domain	PI3_4_KINASE_3	PRKDC ATM	5.48e-03	18	116	2	PS50290
Domain	-	ITSN1 HRNR EFCAB9 RASGRP3 ITSN2 PLCB2	5.81e-03	261	116	6	1.10.238.10
Pathway	REACTOME_MITOTIC_PROMETAPHASE	PDS5B RGPD8 OFD1 CEP290 NCAPG DYNC1LI1 PDS5A PMF1	2.66e-05	202	84	8	MM15362
Pathway	REACTOME_CELL_CYCLE	CUL1 PDS5B RGPD8 OFD1 RTEL1 POLE CEP290 NCAPG2 NCAPG DYNC1LI1 PDS5A ATM PMF1	5.39e-05	603	84	13	MM14635
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	CUL4B PDS5B RGPD8 COG7 KIF4A IKBIP FBXL3 TLK1 INF2 WASHC5 ZNF644 ITSN2 DYNC1LI1 PDS5A GNAL PRKDC ATM PMF1 RGPD5 KPNA2	2.86e-09	1155	120	20	20360068
Pubmed	Comparative structure-function analysis of bromodomain and extraterminal motif (BET) proteins in a gene-complementation system.	BRD3 BRD2 BRD4	4.01e-08	3	120	3	31792058
Pubmed	Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.	BRD3 BRD2 BRD4	4.01e-08	3	120	3	24049186
Pubmed	BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition.	BRD3 BRD2 BRD4	4.01e-08	3	120	3	29437854
Pubmed	Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.	CUL1 BRD3 BRD2 BRD4	4.37e-08	11	120	4	28805820
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CUL4B PDS5B KMT2B ITSN1 SPTBN1 MED14 FAM76B BRD3 TLK1 BRD2 ZNF644 BRD4 DYNC1LI1 PRKDC ATM	7.73e-08	774	120	15	15302935
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	CUL1 POLE SPTBN1 KIF4A SRP72 NCAPG IPO9 BRD2 BRD4 DYNC1LI1 PRKDC ATM KPNA2	1.21e-07	582	120	13	20467437
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	PDS5B SPTBN1 KIF4A SRP72 BRD3 NCAPG BRD2 BRD4 DYNC1LI1 PDS5A PRKDC	1.32e-07	394	120	11	27248496
Pubmed	Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.	BRD3 BRD2 BRD4	1.60e-07	4	120	3	22912406
Pubmed	Expression of BET genes in testis of men with different spermatogenic impairments.	BRD3 BRD2 BRD4	1.60e-07	4	120	3	22035730
Pubmed	Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.	BRD3 BRD2 BRD4	1.60e-07	4	120	3	24248598
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	RPL23A PDS5B SPTBN1 MED14 FAM76B SRP72 BRD3 HRNR BRD2 BRD4 NEMF DYNC1LI1 PDS5A GNA12 PRKDC ATM KPNA2	1.98e-07	1082	120	17	38697112
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	CUL1 PDS5B KMT2B MED14 FAM76B KIF4A SRP72 CIT NCAPG2 TLK1 ZNF644 BRD4 SEPTIN14 MED22 DYNC1LI1 PDS5A PRKDC	2.59e-07	1103	120	17	34189442
Pubmed	Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.	BRD3 BRD2 INF2 GCC2 BRD4	2.69e-07	40	120	5	28805822
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	KMT2B VPS13C ITSN1 CEP290 ADGRB1 BRD3 HRNR CCDC39 ITPR2 TRIM43B PDS5A PRKDC ATM RGL4	2.71e-07	736	120	14	29676528
Pubmed	Defining the membrane proteome of NK cells.	OFD1 CEP290 MED14 KIF4A CIT NCAPG2 IKBIP ITPR2 NCAPG IPO9 GCC2 HS2ST1 LRRC8A DYNC1LI1 PRKDC CMTM7 KPNA2	5.74e-07	1168	120	17	19946888
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CUL4B PDS5B POLE CEP290 BRD3 IKBIP NCAPG BRD2 BRD4 PDS5A KPNA2	7.40e-07	469	120	11	27634302
Pubmed	Intron 1-Mediated Regulation of EGFR Expression in EGFR-Dependent Malignancies Is Mediated by AP-1 and BET Proteins.	BRD3 BRD2 BRD4	7.95e-07	6	120	3	31444232
Pubmed	Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT).	CUL4B KIF4A BRD3 NCAPG2 TLK1	1.36e-06	55	120	5	27114453
Pubmed	BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail.	BRD3 BRD2 BRD4	2.22e-06	8	120	3	31311807
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPL23A CEP104 PDS5B RGPD8 ITSN1 SPTBN1 SRP72 TRIM43 BRD3 TTC3 TRIM43B TLK1 BRD2 ITSN2 GNA12 PRKDC ATM RGPD5	2.32e-06	1442	120	18	35575683
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	CUL4B CUL1 PDS5B ABCB7 COG7 MED14 NCAPG IPO9 HS2ST1 DYNC1LI1 PDS5A	4.08e-06	560	120	11	35241646
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	PDS5B BRD3 NCAPG BRD2 DYNC1LI1 PDS5A KPNA2	5.45e-06	195	120	7	19454010
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	RGPD8 KIF4A SRP72 GIT2 NCAPG2 NCAPG DYNC1LI1 TRAF3IP3 ATM	5.87e-06	370	120	9	22922362
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HDAC9 RTEL1 CEP290 GPD1L TLK1 IPO9 RASGRP3 TLR1 DNAH17 PDS5A	8.64e-06	493	120	10	15368895
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	KIF4A CIT NCAPG2 NCAPG DYNC1LI1 PRKDC KPNA2	8.84e-06	210	120	7	16565220
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PDS5B KMT2B KIF4A BRD3 FSIP2 BRD2 ZNF644 BRD4 PDS5A PMF1 KPNA2	8.85e-06	608	120	11	36089195
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CUL4B CUL1 PDS5B POLE MED14 KIF4A BRD3 NCAPG BRD2 BRD4 MED22 PDS5A PRKDC ATM	1.12e-05	1014	120	14	32416067
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	CUL1 ADGRB1 SRP72 FBP2 HRNR GPD1L IPO9 WASHC5	1.12e-05	304	120	8	32235678
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	RPL23A RGPD8 ITSN1 SPTBN1 KIF4A HRNR ITPR2 INF2 ITSN2 PRKDC RGPD5	1.16e-05	626	120	11	33644029
Pubmed	Nuclear localization of the tyrosine kinase Itk and interaction of its SH3 domain with karyopherin alpha (Rch1alpha).	ITK KPNA2	1.18e-05	2	120	2	11581171
Pubmed	Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis.	PRKDC ATM	1.18e-05	2	120	2	11231155
Pubmed	Intersectin deficiency impairs cortico-striatal neurotransmission and causes obsessive-compulsive behaviors in mice.	ITSN1 ITSN2	1.18e-05	2	120	2	37603735
Pubmed	Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation.	PRKDC ATM	1.18e-05	2	120	2	10464290
Pubmed	Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM.	PRKDC ATM	1.18e-05	2	120	2	27939942
Pubmed	CEP104 and CEP290; Genes with Ciliary Functions Cause Intellectual Disability in Multiple Families.	CEP104 CEP290	1.18e-05	2	120	2	34196201
Pubmed	The DNA damage response kinases DNA-dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM) Are stimulated by bulky adduct-containing DNA.	PRKDC ATM	1.18e-05	2	120	2	21487018
Pubmed	Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation.	BRD2 BRD4	1.18e-05	2	120	2	32151278
Pubmed	Exon Inclusion Modulates Conformational Plasticity and Autoinhibition of the Intersectin 1 SH3A Domain.	ITSN1 ITSN2	1.18e-05	2	120	2	31031201
Pubmed	PDS5 proteins are required for proper cohesin dynamics and participate in replication fork protection.	PDS5B PDS5A	1.18e-05	2	120	2	31757807
Pubmed	Activation of DNA Damage Response Pathways during Lytic Replication of KSHV.	PRKDC ATM	1.18e-05	2	120	2	26057167
Pubmed	BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.	BRD2 BRD4	1.18e-05	2	120	2	23255218
Pubmed	Intersectin associates with synapsin and regulates its nanoscale localization and function.	ITSN1 ITSN2	1.18e-05	2	120	2	29078407
Pubmed	A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.	BRD2 BRD4	1.18e-05	2	120	2	24146614
Pubmed	PDS5A and PDS5B in Cohesin Function and Human Disease.	PDS5B PDS5A	1.18e-05	2	120	2	34070827
Pubmed	The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription.	BRD3 BRD2	1.18e-05	2	120	2	18406326
Pubmed	DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases.	PRKDC ATM	1.18e-05	2	120	2	19071136
Pubmed	Vertebrate intersectin1 is repurposed to facilitate cortical midline connectivity and higher order cognition.	ITSN1 ITSN2	1.18e-05	2	120	2	23447614
Pubmed	Roles of DNA-dependent protein kinase and ATM in cell-cycle-dependent radiation sensitivity in human cells.	PRKDC ATM	1.18e-05	2	120	2	12065055
Pubmed	Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2.	BRD2 BRD4	1.18e-05	2	120	2	35839775
Pubmed	Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break.	PRKDC ATM	1.18e-05	2	120	2	17189255
Pubmed	The human intersectin genes and their spliced variants are differentially expressed.	ITSN1 ITSN2	1.18e-05	2	120	2	11690630
Pubmed	AIF-mediated caspase-independent necroptosis requires ATM and DNA-PK-induced histone H2AX Ser139 phosphorylation.	PRKDC ATM	1.18e-05	2	120	2	22972376
Pubmed	G(2)-M phase-correlative bystander effects are co-mediated by DNA-PKcs and ATM after carbon ion irradiation.	PRKDC ATM	1.18e-05	2	120	2	26774662
Pubmed	WHAT do viruses BET on?	BRD2 BRD4	1.18e-05	2	120	2	20036832
Pubmed	DNA-PKcs and ATM modulate mitochondrial ADP-ATP exchange as an oxidative stress checkpoint mechanism.	PRKDC ATM	1.18e-05	2	120	2	36727301
Pubmed	PDS5A and PDS5B differentially affect gene expression without altering cohesin localization across the genome.	PDS5B PDS5A	1.18e-05	2	120	2	35986423
Pubmed	Deciphering the role of distinct DNA-PK phosphorylations at collapsed replication forks.	PRKDC ATM	1.18e-05	2	120	2	32674014
Pubmed	Chromosomal localization, gene structure and transcription pattern of the ORFX gene, a homologue of the MHC-linked RING3 gene.	BRD3 BRD2	1.18e-05	2	120	2	9373153
Pubmed	Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domain-containing proteins.	ITSN1 ITSN2	1.18e-05	2	120	2	23936226
Pubmed	BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis.	BRD3 BRD4	1.18e-05	2	120	2	28733670
Pubmed	BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.	BRD2 BRD4	1.18e-05	2	120	2	23115324
Pubmed	Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions.	PRKDC ATM	1.18e-05	2	120	2	21245310
Pubmed	Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes.	BRD2 BRD4	1.18e-05	2	120	2	26324948
Pubmed	The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase.	PRKDC ATM	1.18e-05	2	120	2	17593081
Pubmed	Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation.	PRKDC ATM	1.18e-05	2	120	2	20617180
Pubmed	Brd4-Brd2 isoform switching coordinates pluripotent exit and Smad2-dependent lineage specification.	BRD2 BRD4	1.18e-05	2	120	2	28588073
Pubmed	Recruitment of Brd3 and Brd4 to acetylated chromatin is essential for proinflammatory cytokine-induced matrix-degrading enzyme expression.	BRD3 BRD4	1.18e-05	2	120	2	30786900
Pubmed	DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells.	PRKDC ATM	1.18e-05	2	120	2	18172300
Pubmed	Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.	BRD2 BRD4	1.18e-05	2	120	2	16940503
Pubmed	BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.	BRD3 BRD4	1.18e-05	2	120	2	29240787
Pubmed	SARS-CoV-2 E protein interacts with BRD2 and BRD4 SEED domains and alters transcription in a different way than BET inhibition.	BRD2 BRD4	1.18e-05	2	120	2	39066826
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	PDS5B RTEL1 NCAPG2 BRD2 ZNF644 BRD4 PDS5A	1.27e-05	222	120	7	37071664
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	CUL4B RPL23A CUL1 COG7 SPTBN1 NCAPG IPO9 DYNC1LI1 PDS5A PRKDC KPNA2	1.39e-05	638	120	11	33239621
Pubmed	Mutations that affect meiosis in male mice influence the dynamics of the mid-preleptotene and bouquet stages.	GMCL1 PRKDC ATM	1.77e-05	15	120	3	17010969
Pubmed	Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.	ABCB7 SPTBN1 CIT IKBIP IPO9 LRRC8A	1.77e-05	156	120	6	29961565
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	PDS5B POLE ARFGEF1 SRP72 NCAPG2 NCAPG IPO9 INF2 HS2ST1 DYNC1LI1 PDS5A PRKDC KPNA2	2.36e-05	942	120	13	31073040
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KMT2B OFD1 POLE MED14 TTC3 CIT MXRA7 ITPR2 TLK1 BRD2 INF2 BRD4 GNA12 PRKDC	2.89e-05	1105	120	14	35748872
Pubmed	SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.	CREB5 BRD2 INF2	3.15e-05	18	120	3	29996942
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPL23A CUL1 PDS5B VPS13C POLE SPTBN1 SRP72 TTC3 NCAPG IPO9 NEMF DYNC1LI1 PDS5A PRKDC ATM KPNA2	3.25e-05	1425	120	16	30948266
Pubmed	Behavioral analysis in mice deficient for GAREM2 (Grb2-associated regulator of Erk/MAPK subtype2) that is a subtype of highly expressing in the brain.	ITSN1 ITSN2	3.53e-05	3	120	2	31718706
Pubmed	Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.	PRKDC ATM	3.53e-05	3	120	2	9766667
Pubmed	Identification and characterization of FUS/TLS as a new target of ATM.	PRKDC ATM	3.53e-05	3	120	2	18620545
Pubmed	Severe hypoxia increases expression of ATM and DNA-PKcs and it increases their activities through Src and AMPK signaling pathways.	PRKDC ATM	3.53e-05	3	120	2	30224064
Pubmed	DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks.	PRKDC ATM	3.53e-05	3	120	2	18644470
Pubmed	Tagging single nucleotide polymorphisms in phosphoinositide-3-kinase-related protein kinase genes involved in DNA damage "checkpoints" and lung cancer susceptibility.	PRKDC ATM	3.53e-05	3	120	2	18451257
Pubmed	Functional intersection of ATM and DNA-dependent protein kinase catalytic subunit in coding end joining during V(D)J recombination.	PRKDC ATM	3.53e-05	3	120	2	23836881
Pubmed	DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells.	PRKDC ATM	3.53e-05	3	120	2	27733644
Pubmed	Intersectin 2, a new multimodular protein involved in clathrin-mediated endocytosis.	ITSN1 ITSN2	3.53e-05	3	120	2	10922467
Pubmed	Dynamic change of histone H2AX phosphorylation independent of ATM and DNA-PK in mouse skin in situ.	PRKDC ATM	3.53e-05	3	120	2	17923115
Pubmed	DNA damage, metabolism and aging in pro-inflammatory T cells: Rheumatoid arthritis as a model system.	PRKDC ATM	3.53e-05	3	120	2	29101015
Pubmed	NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells.	BRD2 BRD4	3.53e-05	3	120	2	30300821
Pubmed	DNA-PKcs and ATM epistatically suppress DNA end resection and hyperactivation of ATR-dependent G2-checkpoint in S-phase irradiated cells.	PRKDC ATM	3.53e-05	3	120	2	31601897
Pubmed	Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.	BRD2 BRD4	3.53e-05	3	120	2	28262505
Pubmed	Mutations in CCDC39 and CCDC40 are the major cause of primary ciliary dyskinesia with axonemal disorganization and absent inner dynein arms.	RSPH4A CCDC39	3.53e-05	3	120	2	23255504
Pubmed	BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.	BRD3 BRD4	3.53e-05	3	120	2	17934517
Pubmed	Structural mechanism of nuclear transport mediated by importin β and flexible amphiphilic proteins.	CUL4B CUL1	3.53e-05	3	120	2	25435324
Pubmed	Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors.	BRD2 BRD4	3.53e-05	3	120	2	25049379
Pubmed	Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy.	PRKDC ATM	3.53e-05	3	120	2	25205036
Pubmed	Pds5 Regulates Sister-Chromatid Cohesion and Chromosome Bi-orientation through a Conserved Protein Interaction Module.	PDS5B PDS5A	3.53e-05	3	120	2	28343969
Interaction	PWWP2B interactions	BRD3 BRD2 BRD4 PRKDC	3.10e-06	18	117	4	int:PWWP2B
Interaction	RGPD8 interactions	RGPD8 INF2 TRAF3IP3 PMF1 RGPD5 KPNA2	4.52e-06	74	117	6	int:RGPD8
Interaction	UHRF2 interactions	CUL4B KIF4A BRD3 CIT NCAPG2 TLK1 BRD4 PRKDC	2.21e-05	200	117	8	int:UHRF2
Interaction	RCC1 interactions	HDAC9 KMT2B RGPD8 BRD3 CIT BRD2 BRD4 RGPD5	2.29e-05	201	117	8	int:RCC1
Interaction	CCDC42 interactions	MID2 CIT CCDC42	3.04e-05	11	117	3	int:CCDC42
Interaction	SMC1A interactions	CUL4B PDS5B POLE ITSN1 TRIM43 CIT BRD4 NEMF PDS5A PRKDC ATM	3.24e-05	418	117	11	int:SMC1A
Interaction	H2AC4 interactions	CUL4B CUL1 PDS5B SPTBN1 SRP72 CIT NCAPG IPO9 BRD2 BRD4 DYNC1LI1 PRKDC	3.87e-05	506	117	12	int:H2AC4
Interaction	SPDYE7P interactions	BRD3 BRD2 BRD4	4.04e-05	12	117	3	int:SPDYE7P
Interaction	DISC1 interactions	ABCB7 RGPD8 OFD1 ITSN1 SPTBN1 CEP290 CIT IKBIP IPO9 LRRC8A RGPD5	4.11e-05	429	117	11	int:DISC1
Interaction	GPR17 interactions	PDS5B COG7 ARFGEF1 ITPR2 GPD1L NCAPG PDS5A PRKDC ATM	4.11e-05	283	117	9	int:GPR17
Interaction	CBX5 interactions	CUL4B RPL23A HDAC9 BRD3 CIT BRD2 ZNF644 BRD4 PMF1 KPNA2	4.36e-05	356	117	10	int:CBX5
Interaction	ZNF711 interactions	RPL23A BRD3 BRD2 BRD4	4.37e-05	34	117	4	int:ZNF711
Interaction	CBX1 interactions	CUL4B BRD3 CIT IPO9 BRD2 ZNF644 BRD4 PMF1 KPNA2	4.71e-05	288	117	9	int:CBX1
Interaction	LPAR4 interactions	PDS5B PDS5A PRKDC ATM	5.51e-05	36	117	4	int:LPAR4
Interaction	ZNF330 interactions	PDS5B KMT2B POLE KIF4A BRD3 CREB5 IPO9 BRD2 ZNF644 PDS5A KPNA2	5.83e-05	446	117	11	int:ZNF330
Interaction	DHX38 interactions	BRD3 CIT ITGB3 BRD2 BRD4 IFIT1B PRKDC	6.11e-05	170	117	7	int:DHX38
Interaction	H3C1 interactions	CUL4B PDS5B KMT2B CEP290 MED14 KIF4A SRP72 BRD3 TLK1 BRD2 GCC2 ZNF644 BRD4 PDS5A PRKDC ATM	6.51e-05	901	117	16	int:H3C1
Interaction	XRCC1 interactions	CUL1 BRD3 CIT NCAPG BRD2 BRD4 PRKDC	6.83e-05	173	117	7	int:XRCC1
Interaction	TNFSF13B interactions	NCAPG2 MALT1 NCAPG IPO9 PDS5A PRKDC	6.85e-05	119	117	6	int:TNFSF13B
Interaction	SMARCA4 interactions	CUL4B CUL1 HDAC9 BRD3 TTC3 CIT BRD2 BRD4 ATM TBX20 KPNA2	7.98e-05	462	117	11	int:SMARCA4
Interaction	PCNT interactions	OFD1 SPTBN1 CEP290 TRIM43 IKBIP IPO9 DYNC1LI1 TMOD1	8.28e-05	241	117	8	int:PCNT
Interaction	RNF123 interactions	KMT2B VPS13C ITSN1 CEP290 ADGRB1 BRD3 HRNR CCDC39 ITPR2 TRIM43B INF2 PDS5A PRKDC ATM RGL4	8.53e-05	824	117	15	int:RNF123
Interaction	RPS7 interactions	CUL4B RPL23A CUL1 ABCB7 VPS13C SRP72 CIT ITPR2 BRD4 NEMF DYNC1LI1	8.61e-05	466	117	11	int:RPS7
Interaction	FAM234A interactions	PDS5B COG7 ARFGEF1 PDS5A PRKDC ATM	9.41e-05	126	117	6	int:FAM234A
Interaction	CD80 interactions	PDS5B GPD1L PDS5A PRKDC ATM	9.68e-05	79	117	5	int:CD80
Interaction	SREK1 interactions	CUL4B RPL23A CUL1 SPTBN1 CEP290 BRD3 CIT	9.71e-05	183	117	7	int:SREK1
Interaction	CBX3 interactions	CUL4B CUL1 HDAC9 PDS5B KMT2B KIF4A BRD3 CIT BRD2 ZNF644 BRD4 PDS5A PMF1	9.74e-05	646	117	13	int:CBX3
Interaction	MED24 interactions	MED14 BRD3 BRD2 BRD4 MED22 SUCO	1.03e-04	128	117	6	int:MED24
Interaction	HSP90B1 interactions	CUL4B CUL1 RELCH VPS13C SPTBN1 CIT ITGB3 IPO9 BRD4 TLR1 DNAH17 NEMF LRRC8A	1.04e-04	650	117	13	int:HSP90B1
Interaction	NOVA2 interactions	BRD3 BRD2 BRD4	1.22e-04	17	117	3	int:NOVA2
Interaction	NHEJ1 interactions	BRD4 PRKDC ATM	1.22e-04	17	117	3	int:NHEJ1
Interaction	RPL35A interactions	CUL4B RPL23A CUL1 PDS5B SRP72 BRD3 CIT BRD4 TMOD1 PDS5A	1.27e-04	405	117	10	int:RPL35A
Interaction	MED30 interactions	MED14 BRD3 BRD2 BRD4 MED22	1.30e-04	84	117	5	int:MED30
Interaction	POLR1G interactions	CUL1 PDS5B KMT2B BRD3 CIT NCAPG2 BRD2 ZNF644 BRD4 PDS5A KPNA2	1.32e-04	489	117	11	int:POLR1G
Interaction	AATK interactions	CUL1 RELCH ITSN1 WASHC5 GCC2 ITSN2 PRKDC	1.40e-04	194	117	7	int:AATK
Interaction	C19orf38 interactions	PDS5B NCAPG2 NCAPG PDS5A PRKDC	1.45e-04	86	117	5	int:C19orf38
Interaction	MAS1 interactions	PDS5B NCAPG PDS5A PRKDC ATM	1.45e-04	86	117	5	int:MAS1
Interaction	NPIPB6 interactions	RGPD8 RGPD5 KPNA2	1.46e-04	18	117	3	int:NPIPB6
Interaction	H3C3 interactions	PDS5B KMT2B KIF4A BRD3 FSIP2 BRD2 ZNF644 BRD4 PDS5A PMF1 KPNA2	1.46e-04	495	117	11	int:H3C3
Interaction	CFAP410 interactions	CEP104 CUL1 CEP290 GMCL1	1.87e-04	49	117	4	int:CFAP410
Interaction	DNAJC7 interactions	RPL23A OFD1 VPS13C POLE TTC3 NCAPG2 BRD2 BRD4 PRKDC ATM	1.88e-04	425	117	10	int:DNAJC7
Interaction	MED1 interactions	MED14 BRD3 CIT BRD2 BRD4 MED22 ATM	2.02e-04	206	117	7	int:MED1
Interaction	CTDP1 interactions	ABCB7 MED14 ARFGEF1 CIT NCAPG2 PRKDC ATM	2.08e-04	207	117	7	int:CTDP1
Interaction	UHRF1 interactions	CUL1 BRD3 CIT IPO9 BRD2 BRD4 ATM	2.14e-04	208	117	7	int:UHRF1
Interaction	KPNA2 interactions	CUL4B CUL1 RGPD8 MROH2A CIT ITK GMCL1 NCAPG BRD4 RGPD5 KPNA2	2.21e-04	519	117	11	int:KPNA2
Interaction	OPALIN interactions	PDS5B ABCB7 ARFGEF1 NCAPG2 PDS5A PRKDC ATM	2.21e-04	209	117	7	int:OPALIN
Interaction	PSMD2 interactions	RGPD8 OFD1 MID2 CIT ITGB3 IPO9 GCC2 BRD4 PDS5A RGPD5	2.26e-04	435	117	10	int:PSMD2
Interaction	ST7 interactions	CUL4B PCDHB6 IKBIP MXRA7 ITPR2 ZFYVE9 INF2 SUCO MCOLN3	2.65e-04	362	117	9	int:ST7
Interaction	CEBPA interactions	CUL1 PDS5B KMT2B SPTBN1 MED14 FAM76B KIF4A SRP72 CIT NCAPG2 TLK1 ZNF644 BRD4 SEPTIN14 MED22 DYNC1LI1 PDS5A PRKDC	2.96e-04	1245	117	18	int:CEBPA
Interaction	MED4 interactions	OFD1 ITSN1 CEP290 MED14 BRD3 GIT2 NCAPG BRD4 MED22 RGPD5	2.96e-04	450	117	10	int:MED4
Interaction	CHAF1B interactions	BRD3 CIT BRD2 ZNF644 BRD4 PMF1	3.23e-04	158	117	6	int:CHAF1B
Interaction	POLR2H interactions	CUL1 MED14 BRD3 BRD4 MED22 PRKDC KPNA2	3.27e-04	223	117	7	int:POLR2H
Interaction	SNAI1 interactions	CUL4B RPL23A CUL1 MID2 BRD3 NCAPG IPO9 BRD2 BRD4 PRKDC ATM	3.40e-04	546	117	11	int:SNAI1
Interaction	TFPT interactions	MID2 BRD3 GIT2 BRD2 GCC2 RGPD5	3.45e-04	160	117	6	int:TFPT
Interaction	CENPA interactions	PDS5B KMT2B POLE KIF4A BRD3 BRD2 ZNF644 PDS5A PRKDC	3.57e-04	377	117	9	int:CENPA
Interaction	HAUS6 interactions	CEP104 OFD1 CEP290 GIT2 CIT INF2	3.57e-04	161	117	6	int:HAUS6
Interaction	MED19 interactions	MED14 BRD3 BRD2 BRD4 MED22	3.85e-04	106	117	5	int:MED19
Interaction	ZNF740 interactions	BRD3 BRD2 BRD4	4.00e-04	25	117	3	int:ZNF740
Interaction	SNW1 interactions	CUL4B CUL1 POLE SPTBN1 KIF4A SRP72 CIT NCAPG IPO9 BRD4 PRKDC ATM KPNA2	4.01e-04	747	117	13	int:SNW1
Interaction	RFC1 interactions	CUL1 POLE BRD3 BRD2 BRD4 PDS5A ATM	4.05e-04	231	117	7	int:RFC1
Interaction	RAD21 interactions	RPL23A PDS5B TRIM43 CIT NCAPG BRD4 PDS5A PRKDC KPNA2	4.08e-04	384	117	9	int:RAD21
Interaction	MYH9 interactions	CUL1 SPTBN1 ARFGEF1 CIT ITGB3 ITPR2 FCF1 NCAPG CCDC42 INF2 BRD4 TMOD1 KPNA2	4.38e-04	754	117	13	int:MYH9
Interaction	MECP2 interactions	RPL23A PDS5B SPTBN1 MED14 FAM76B SRP72 BRD3 HRNR FCF1 BRD2 BRD4 NEMF DYNC1LI1 PDS5A GNA12 PRKDC ATM KPNA2	4.41e-04	1287	117	18	int:MECP2
Cytoband	3p22.3	GPD1L DYNC1LI1 CMTM7	7.42e-05	31	120	3	3p22.3
Cytoband	9q22.3	FBP2 TMOD1	4.40e-04	12	120	2	9q22.3
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	RGPD8 SRP72 TTC3 IFIT1B RGPD5	1.02e-04	115	73	5	769
GeneFamily	Cullins	CUL4B CUL1	4.43e-04	8	73	2	1032
GeneFamily	EF-hand domain containing	ITSN1 HRNR EFCAB9 RASGRP3 ITSN2	1.92e-03	219	73	5	863
GeneFamily	Armadillo repeat containing\|Importins	IPO9 KPNA2	2.36e-03	18	73	2	596
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CUL4B PDS5B VPS13C CEP290 ARFGEF1 FBXL3 ITPR2 WASHC5 GCC2 ZNF644 ITSN2 NEMF ATM SUCO	1.74e-06	656	119	14	M18979
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	HDAC9 PDS5B SPTBN1 KIF4A TTC3 NCAPG2 NCAPG PDS5A PRKDC	2.20e-06	250	119	9	M11318
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2	POLE MED14 KIF4A TTC3 CIT ITGB3 NCAPG2 ITK NCAPG MCOLN3 KPNA2	1.72e-05	422	114	11	GSM476658_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	ABCB7 VPS13C POLE CEP290 TTC3 CIT NCAPG NEMF LRRC8A PDS5A PRKDC ATM	2.94e-05	532	114	12	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CUL1 VPS13C CEP290 TTC3 TLK1 GCC2 ZNF644 BRD4 KPNA2	3.29e-09	198	119	9	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	CEP104 VPS13C CEP290 TTC3 CCDC39 GCC2 ZNF644 BRD4 NEMF	3.44e-09	199	119	9	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	VPS13C CEP290 ARFGEF1 TTC3 GCC2 ZNF644 BRD4 ITSN2	6.56e-08	199	119	8	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN1 TTC3 ITK GCC2 ITSN2 PDS5A SUCO	6.04e-07	182	119	7	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN1 TTC3 ITK GCC2 ITSN2 PDS5A SUCO	6.04e-07	182	119	7	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PDS5B POLE KIF4A CIT NCAPG2 NCAPG IPO9	8.06e-07	190	119	7	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLVAP POLE KIF4A CIT NCAPG2 NCAPG PMF1	9.59e-07	195	119	7	5790b47b0e028e49b99bda8d6d9e80ac79208cdf
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	OFD1 SPTBN1 TTC3 ITK GCC2 TRAF3IP3 ATM	1.03e-06	197	119	7	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	CEP104 VPS13C ITSN1 CEP290 TTC3 GCC2 BRD4	1.10e-06	199	119	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	POLE TBC1D7 MED14 KIF4A CIT NCAPG	6.94e-06	172	119	6	7c238a7375341d4647ba7274d93fddfb6fae7ce4
ToppCell	normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	NBEAL1 SPTBN1 ITK GCC2 IFIT1B ATM	8.45e-06	178	119	6	fa3585383a1e7da460c88a802aaa81246d681b6b
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POLE CEP290 NCAPG2 AOC3 PDE5A ATM	9.29e-06	181	119	6	274c0b768925cd5804483303f8c5ebd17a534c41
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIF4A CIT NCAPG2 NCAPG INF2 KPNA2	1.02e-05	184	119	6	a0831e850bc0b585296ed350fdd075c1f730308e
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA13 POLE KIF4A NCAPG2 NCAPG GRAMD1C	1.05e-05	185	119	6	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	POLE KIF4A CIT NCAPG2 NCAPG KPNA2	1.19e-05	189	119	6	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	(02)_Cycling_Basal_(regeneration)\|World / shred by cell type and Timepoint	POLE KIF4A NCAPG2 NCAPG PMF1 KPNA2	1.22e-05	190	119	6	53f017a11ca5ebe9025558e12cedc409cab2e5aa
ToppCell	Endothelial-D_(cycle)\|World / shred on cell class and cell subclass (v4)	PLVAP KIF4A CIT NCAPG2 NCAPG KPNA2	1.26e-05	191	119	6	49a4d8f181558e3be9527a8ff9a178f3bb01323c
ToppCell	E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLVAP KIF4A CIT NCAPG RASGRP3 KPNA2	1.26e-05	191	119	6	efe0cb0b6602621f5eda72a723b83b38bf15607f
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	KIF4A CIT NCAPG2 IKBIP NCAPG KPNA2	1.26e-05	191	119	6	0ba5b112a82e489f5a21966f78a403a7436ce73b
ToppCell	E17.5-Endothelial-proliferative_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLVAP KIF4A CIT NCAPG RASGRP3 KPNA2	1.26e-05	191	119	6	00676c598f6dae0ff9158d064248f1265432f3e1
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KIF4A CIT NCAPG2 NCAPG PDE5A KPNA2	1.26e-05	191	119	6	f764cc21fef87ebad765011098f647ae1bdf6158
ToppCell	ASK428-Immune-T_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	RPL23A NBEAL1 ITK P2RY10 TRAF3IP3 RGL4	1.30e-05	192	119	6	121cb8c61002f20e1d287b8a7e67a30bb163e74a
ToppCell	droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF4A CIT NCAPG2 NCAPG PMF1 KPNA2	1.30e-05	192	119	6	96f23d6e8604d1cb24910d3118d8171b57c93e14
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLVAP MID2 SPTBN1 AFAP1L1 GCC2 RASGRP3	1.30e-05	192	119	6	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF4A ITGB3 CREB5 MXRA7 AFAP1L1 NCAPG	1.30e-05	192	119	6	a42aed9e563f5f4af029b8804c104f11ad227a8f
ToppCell	Proliferating\|World / shred by cell class for mouse tongue	KIF4A CIT NCAPG2 NCAPG PMF1 KPNA2	1.30e-05	192	119	6	f081f3f957cc782294e118fcc1055f6a4264ee98
ToppCell	P07-Endothelial-proliferative_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLVAP KIF4A CIT NCAPG2 NCAPG KPNA2	1.34e-05	193	119	6	1e95ef29357969ee385b4717c0b5a497390ac260
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	CUL4B NBEAL1 SRP72 GCC2 PDS5A PRKDC	1.34e-05	193	119	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	control-Myeloid-Immature_Neutrophils_2\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ABCA13 POLE KIF4A CIT NCAPG RGL4	1.34e-05	193	119	6	33349830e9eba506470ad3661fad5e5a283d20ca
ToppCell	P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLVAP KIF4A CIT NCAPG2 NCAPG KPNA2	1.34e-05	193	119	6	0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd
ToppCell	droplet-Tongue-nan-3m-Epithelial-proliferating\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF4A CIT NCAPG2 NCAPG PMF1 KPNA2	1.38e-05	194	119	6	2cac1b9c4da01faaec9a67ec06f47a7060760225
ToppCell	(3)_Chondrocytes-(33)_Chondro-prol/rest\|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis	KIF4A CIT NCAPG2 NCAPG CMTM7 PMF1	1.38e-05	194	119	6	4a207630d72059345b10010f5cfd3b1462458324
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLVAP POLE KIF4A CIT NCAPG2 NCAPG	1.38e-05	194	119	6	3a49c7c86036e09a8cd0114988380d04ad1a26fb
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SPTBN1 TTC3 ITK GCC2 TRAF3IP3 ATM	1.42e-05	195	119	6	4bdedd924564a260841a9153604026b57487c83d
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 KIF4A NCAPG TLR1 PLCB2 TBX20	1.46e-05	196	119	6	53d1f9e9f009d1417a19ca6f9a83ecdf7776ef88
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLVAP KIF4A CIT NCAPG2 NCAPG RASGRP3	1.46e-05	196	119	6	20383d576708b7e4bfce3e9fe40548cce496e3cb
ToppCell	COVID-19-lung-Proliferative_fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KIF4A TDO2 CIT NCAPG2 NCAPG KPNA2	1.46e-05	196	119	6	ca91d5e325875e7444809b80fcbd491d8899ea36
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLVAP KIF4A CIT NCAPG2 NCAPG RASGRP3	1.46e-05	196	119	6	0644bd14a944b9c9759a295dfdd5e67a4775f20a
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL23A NBEAL1 ITK GCC2 TRAF3IP3 ATM	1.50e-05	197	119	6	9373fcd728016b7af1abd7d88c47b7db79eb6a2f
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLVAP KIF4A CIT NCAPG2 NCAPG RASGRP3	1.50e-05	197	119	6	a41420d4b6d502c2f594c054c7efbb5d4eac83ff
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ENOSF1 SPTBN1 TTC3 ITK GCC2 ATM	1.50e-05	197	119	6	836dd8110d5689f944ad1d301def38c32278b5b5
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg\|ICU-SEP / Disease, condition lineage and cell class	FSIP2 INF2 P2RY10 TRAF3IP3 RGPD5 RGL4	1.50e-05	197	119	6	c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26
ToppCell	normal-na-Lymphocytic_T-T8_naive\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RPL23A NBEAL1 ITK GCC2 ATM RGL4	1.55e-05	198	119	6	61b7e313967acff0a7cfc0a797f78494d3d08e29
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL23A NBEAL1 ITK GCC2 TRAF3IP3 ATM	1.55e-05	198	119	6	239bef79ebaa6e1d8618c670c1050a02362058ee
ToppCell	severe-Myeloid-Immature_Neutrophils_2\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ABCA13 POLE KIF4A CIT NCAPG2 NCAPG	1.55e-05	198	119	6	844f534551483c89ef789d1cfeb4680e54f794b2
ToppCell	severe-Myeloid-Immature_Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ABCA13 POLE KIF4A CIT NCAPG2 NCAPG	1.55e-05	198	119	6	e36303628af3139310c1d7a84d2919b7319bbda4
ToppCell	normal-na-Lymphocytic_T-T8_naive-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RPL23A NBEAL1 ITK GCC2 ATM RGL4	1.55e-05	198	119	6	ac8e21629991e47796e2c0a201a6d3bd8cd30b85
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 KIF4A CIT NCAPG2 NCAPG KPNA2	1.55e-05	198	119	6	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLVAP KIF4A AFAP1L1 NCAPG RASGRP3 KPNA2	1.55e-05	198	119	6	604fb20ca1aaf8f07067a8e1593a30ba335891f7
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RELCH ARFGEF1 ITK ZNF644 ATM RGPD5	1.59e-05	199	119	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T8_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NBEAL1 ITK GCC2 TRAF3IP3 ATM RGL4	1.59e-05	199	119	6	40eb207fa0f07e2e4d0be69530b8f61f7ea49c73
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	VPS13C CEP290 TTC3 GCC2 BRD4 ITSN2	1.59e-05	199	119	6	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	Healthy_Control-Lymphoid-T\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	KIF4A ITK NCAPG P2RY10 TRAF3IP3 RGL4	1.59e-05	199	119	6	f22438fc9c02d0a4d7c936f9420b913aca851ea1
ToppCell	COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	RPL23A SPTBN1 TTC3 ITK GCC2 ATM	1.59e-05	199	119	6	885bc902b6e2af0b61e452c4154160cd3f1cf98e
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tcm\|Leuk-UTI / Disease, condition lineage and cell class	RPL23A ENOSF1 RSPH4A TTC3 ITK GCC2	1.59e-05	199	119	6	6a1d84f61e1efaab541910926d6911122372659f
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T8_naive-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NBEAL1 ITK GCC2 TRAF3IP3 ATM RGL4	1.59e-05	199	119	6	6ed413872301707dc73ae66365bee94cd38a292c
ToppCell	Control-Control-Lymphocyte-T/NK-CD8+_T_naive\|Control / Disease, condition lineage and cell class	SPTBN1 ITK GCC2 TRAF3IP3 ATM RGL4	1.64e-05	200	119	6	906de95adc9716982ab32f216dddeb52639bad06
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	KIF4A CIT NCAPG2 NCAPG PRKDC KPNA2	1.64e-05	200	119	6	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	KIF4A CIT NCAPG2 NCAPG PRKDC KPNA2	1.64e-05	200	119	6	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	POLE KIF4A CIT NCAPG2 NCAPG	3.02e-05	134	119	5	4d8f7ddad02fe76a614771e115ebb8e04623ba85
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MROH2A CIT CREB5 MXRA7 PDE5A	4.41e-05	145	119	5	590ba937c741ae67460f303eca88b1cd3ac87f64
ToppCell	368C-Lymphocytic-NK_cells\|368C / Donor, Lineage, Cell class and subclass (all cells)	OFD1 RTEL1 KIF4A NCAPG TRAF3IP3	6.43e-05	157	119	5	ef5c0ace4cd500b6cc50fb7076298f3d3543b40c
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RELCH POLE MROH2A ITK GNAL	8.86e-05	168	119	5	a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	POLE KIF4A NCAPG2 NCAPG KPNA2	9.11e-05	169	119	5	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIF4A CIT NCAPG2 NCAPG KPNA2	9.11e-05	169	119	5	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	facs-SCAT-Fat-18m-Lymphocytic-T_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP5B KIF4A ITK P2RY10 MCOLN3	9.11e-05	169	119	5	700a3a36c379872585204caa6a6cc269b036ae22
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RSPH4A SPTBN1 PCDHA11 AFAP1L1 TMOD1	9.37e-05	170	119	5	4848965bc7e9356c6601bb41eeea1553d2eea87e
ToppCell	facs\|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2B LRRC8A DYNC1LI1 GNA12 GNAL	9.63e-05	171	119	5	c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLVAP SPTBN1 AFAP1L1 EFCAB9 RASGRP3	9.63e-05	171	119	5	b3e6e31dfe3623b960ccf692fdbd236fa4039923
ToppCell	droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HDAC9 MROH2A TBC1D7 CREB5 P2RY10	9.90e-05	172	119	5	b043d4f81dced7fb3326043f68474123be47cc5d
ToppCell	facs-Heart-RA-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MALT1 DNAH17 P2RY10 TRAF3IP3 PMF1	1.02e-04	173	119	5	49030c2dd04b592655df1a667e2f90efb499e0a5
ToppCell	facs-Heart-RA-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MALT1 DNAH17 P2RY10 TRAF3IP3 PMF1	1.02e-04	173	119	5	1cfbab6603f8baf8e238837bb72740c43a7dc0ec
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLVAP POLE KIF4A NCAPG2 NCAPG	1.04e-04	174	119	5	c988471207ba06195bc3e41056435e8c31c20bbe
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLVAP KIF4A CIT NCAPG2 NCAPG	1.07e-04	175	119	5	d43ae33a6256606ce848247cad32d74f21b38988
ToppCell	facs\|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2B LRRC8A DYNC1LI1 GNA12 GNAL	1.07e-04	175	119	5	53e96956019f984decc1c81376ebc88fbf3c4d40
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 AFAP1L1 RASGRP3 AOC3 TMOD1	1.10e-04	176	119	5	64e426f5e84884ce2c29acf6f4b958962a63927f
ToppCell	(01)_Cycling_Basal_(homeostasis)\|World / shred by cell type and Timepoint	KIF4A CIT NCAPG PMF1 KPNA2	1.13e-04	177	119	5	05c57578142a6662f18b294d5cc11e6efd6b0f8e
ToppCell	Healthy-RBC\|Healthy / disease group, cell group and cell class	KIF4A CIT NCAPG IFIT1B TMOD1	1.13e-04	177	119	5	945d72ab52efa9a9468daace9f9ec676a891d963
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NBEAL1 GCC2 TRAF3IP3 ATM RGL4	1.13e-04	177	119	5	db6de487ef7976b444afadbf3ac60b3259925566
ToppCell	P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KIF4A CIT NCAPG2 NCAPG KPNA2	1.26e-04	181	119	5	e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d
ToppCell	P28-Endothelial-proliferative_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KIF4A CIT NCAPG2 NCAPG KPNA2	1.26e-04	181	119	5	2be3d44619adb25d339e7a27b500a56e07e8de01
ToppCell	IIH-cycling-\|IIH / Condition, Cell_class and T cell subcluster	KIF4A CIT NCAPG2 NCAPG KPNA2	1.26e-04	181	119	5	7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078
ToppCell	IIH-cycling\|IIH / Condition, Cell_class and T cell subcluster	KIF4A CIT NCAPG2 NCAPG KPNA2	1.26e-04	181	119	5	ec3e782ce93dcfe1a54fb7284e4e39063614b0e2
ToppCell	Healthy_Control-Lymphoid-T-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	SPTBN1 KIF4A CIT NCAPG KPNA2	1.26e-04	181	119	5	ac1ee313910c05b1b3cb497bae14565464919c21
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 KIF4A CIT NCAPG2 NCAPG	1.26e-04	181	119	5	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 KIF4A CIT NCAPG2 NCAPG	1.26e-04	181	119	5	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	Leuk-UTI-Lymphocyte-T_NK-CD8_Naive\|Leuk-UTI / Disease, Lineage and Cell Type	ITK AFAP1L1 GCC2 TRAF3IP3 RGL4	1.29e-04	182	119	5	3500a826d86beb98980e2b24e074b02e8e2f957e
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PLVAP MID2 POLE NCAPG RASGRP3	1.29e-04	182	119	5	ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITPR2 MALT1 RASGRP3 ITSN2 SUCO	1.29e-04	182	119	5	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NBEAL1 GCC2 TRAF3IP3 ATM RGL4	1.29e-04	182	119	5	3a3ed195c15d33d46a2f395cb93018e4bba28353
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLVAP AFAP1L1 NCAPG RASGRP3 KPNA2	1.32e-04	183	119	5	52af3c943116073c8ddd207b664342960b88929b
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA13 POLE KIF4A NCAPG2 NCAPG	1.32e-04	183	119	5	6c1d7ce60e67bf1df364a4e177c351e7313eb41f
ToppCell	normal-na-Lymphocytic_T-T8_naive-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	NBEAL1 ITK GCC2 TRAF3IP3 ATM	1.36e-04	184	119	5	4a81190b36d197736663e6177d3b76c1cb6282d6
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C SPTBN1 GCC2 ITSN2 PDS5A	1.36e-04	184	119	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDS5B VPS13C KIF4A AFAP1L1 DNAH17	1.36e-04	184	119	5	e7b9c69fc77040c5191ad8089697051e2589c30e
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRD3 TTC3 ITGB3 MXRA7 RASGRP3	1.43e-04	186	119	5	37860daeecd6d412bd3797f30496a56da667fbd1
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRD3 TTC3 ITGB3 MXRA7 RASGRP3	1.43e-04	186	119	5	60830822d3de3147816693404fd03392e04c2b8e
ToppCell	TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell\|TCGA-Uvea / Sample_Type by Project: Shred V9	ITGB3 ITPR2 WASHC5 PRKDC KPNA2	1.43e-04	186	119	5	e8580a2093eb7e50aad55ec7fada850d2fed8ae1
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRD3 TTC3 ITGB3 MXRA7 RASGRP3	1.43e-04	186	119	5	baebeffdd426ce767190ddefc857cc78e6a58d36
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	NBEAL1 MED14 HNF4G GCC2 ZNF644	1.43e-04	186	119	5	03db813598b67b1e08f759758a1c2023396921fa
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A	PDS5B INPP5B SPTBN1 CEP290 MED14 IPO9 HS2ST1 PDS5A PRKDC	6.12e-07	185	120	9	2927_DN
Drug	Benzonatate [104-31-4]; Up 200; 6.6uM; PC3; HT_HG-U133A	KMT2B VPS13C CEP290 MFSD9 ITPR2 FCF1 ZFYVE9 GNA12	9.64e-06	196	120	8	1801_UP
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A	CUL4B PDS5B MID2 INPP5B POLE MFSD9 GIT2 MED22	1.00e-05	197	120	8	2052_DN
Drug	16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A	HDAC9 ACADS RTEL1 INPP5B SPTBN1 MED14 MFSD9 GRAMD1C	1.04e-05	198	120	8	6592_DN
Drug	Clopamide [636-54-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ACADS INPP5B SPTBN1 CEP290 TLK1 TLR1 PDE5A GNAL	1.08e-05	199	120	8	3220_UP
Disease	Gastric Adenocarcinoma	BRD3 ITK BRD2 ATM	2.79e-05	45	114	4	C0278701
Disease	Medulloblastoma	BRD3 BRD2 BRD4 ATM	4.24e-05	50	114	4	C0025149
Disease	hypothyroidism	INPP5B FAM76B ITGB3 ITK LRRC8A P2RY10 GNA12	1.22e-04	284	114	7	EFO_0004705
Disease	Writer's Cramp	KMT2B GNAL	3.07e-04	7	114	2	C4316810
Disease	Dystonia Disorders	KMT2B GNAL	3.07e-04	7	114	2	C0393593
Disease	Idiopathic familial dystonia	KMT2B GNAL	3.07e-04	7	114	2	C0393598
Disease	Adult-Onset Idiopathic Focal Dystonias	KMT2B GNAL	3.07e-04	7	114	2	C0752198
Disease	Adult-Onset Dystonias	KMT2B GNAL	3.07e-04	7	114	2	C0752197
Disease	Adult-Onset Idiopathic Torsion Dystonias	KMT2B GNAL	3.07e-04	7	114	2	C0752199
Disease	Autosomal Dominant Familial Dystonia	KMT2B GNAL	3.07e-04	7	114	2	C0752200
Disease	Childhood Onset Dystonias	KMT2B GNAL	3.07e-04	7	114	2	C0752202
Disease	Autosomal Recessive Familial Dystonia	KMT2B GNAL	3.07e-04	7	114	2	C0752201
Disease	Dystonia, Primary	KMT2B GNAL	3.07e-04	7	114	2	C0752203
Disease	Dystonias, Sporadic	KMT2B GNAL	3.07e-04	7	114	2	C0752206
Disease	Dystonia, Secondary	KMT2B GNAL	3.07e-04	7	114	2	C0752205
Disease	Pseudodystonia	KMT2B GNAL	3.07e-04	7	114	2	C0752208
Disease	Familial Dystonia	KMT2B GNAL	3.07e-04	7	114	2	C0752207
Disease	Focal Dystonia	KMT2B GNAL	3.07e-04	7	114	2	C0743332
Disease	female breast cancer (is_implicated_in)	RTEL1 ATM	4.08e-04	8	114	2	DOID:0050671 (is_implicated_in)
Disease	anemia (phenotype), response to ribavirin	RASGRP3 DNAH17	5.23e-04	9	114	2	EFO_0004272, GO_1901559
Disease	Combined immunodeficiency	ITK MALT1 PRKDC	5.38e-04	41	114	3	C0494261
Disease	Childhood Medulloblastoma	BRD3 BRD2 BRD4	6.19e-04	43	114	3	C0278510
Disease	Melanotic medulloblastoma	BRD3 BRD2 BRD4	6.19e-04	43	114	3	C1275668
Disease	Medullomyoblastoma	BRD3 BRD2 BRD4	6.19e-04	43	114	3	C0205833
Disease	Desmoplastic Medulloblastoma	BRD3 BRD2 BRD4	6.19e-04	43	114	3	C0751291
Disease	Adult Medulloblastoma	BRD3 BRD2 BRD4	6.19e-04	43	114	3	C0278876
Disease	Short Stature, CTCAE	RSPH4A FBXL3	6.52e-04	10	114	2	C2919142
Disease	Short stature	RSPH4A FBXL3	6.52e-04	10	114	2	C0349588
Disease	gastric adenocarcinoma (is_implicated_in)	RTEL1 ABCA13	7.95e-04	11	114	2	DOID:3717 (is_implicated_in)
Disease	Primary Ciliary Dyskinesia	OFD1 RSPH4A CCDC39	8.05e-04	47	114	3	C4551720
Disease	mismatch repair cancer syndrome (is_implicated_in)	POLE ASTE1	9.52e-04	12	114	2	DOID:0112182 (is_implicated_in)
Disease	Alzheimer disease, Cognitive impairment	HDAC9 HNF4G	1.50e-03	15	114	2	HP_0100543, MONDO_0004975
Disease	Ischemic stroke, tissue plasminogen activator measurement	HDAC9 PMF1	1.50e-03	15	114	2	EFO_0004791, HP_0002140
Disease	Ischemic stroke, plasminogen activator inhibitor 1 measurement	HDAC9 PMF1	1.71e-03	16	114	2	EFO_0004792, HP_0002140
Disease	Benign neoplasm of stomach	POLE ATM	1.94e-03	17	114	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	POLE ATM	1.94e-03	17	114	2	C0496905
Disease	Dystonia, Limb	KMT2B GNAL	1.94e-03	17	114	2	C0751093
Disease	Dystonia, Diurnal	KMT2B GNAL	1.94e-03	17	114	2	C0393610
Disease	Carcinoma in situ of stomach	POLE ATM	1.94e-03	17	114	2	C0154060
Disease	factor XI measurement, Ischemic stroke	HDAC9 PMF1	1.94e-03	17	114	2	EFO_0004694, HP_0002140
Disease	Dystonia, Paroxysmal	KMT2B GNAL	2.17e-03	18	114	2	C0393588
Disease	factor VIII measurement, Ischemic stroke	HDAC9 PMF1	2.42e-03	19	114	2	EFO_0004630, HP_0002140
Disease	myocardial infarction	HDAC9 NBEAL1 INPP5B IPO9 PLCB2 TBX20	2.43e-03	350	114	6	EFO_0000612
Disease	congenital heart disease (implicated_via_orthology)	KMT2B PLCB2 TBX20	2.44e-03	69	114	3	DOID:1682 (implicated_via_orthology)
Disease	neutrophil count	SPTBN1 PCDHA11 BRD3 CIT CREB5 ITPR2 MED22 ITSN2 GNA12 PLCB2 PRKDC TRAF3IP3 PMF1	2.65e-03	1382	114	13	EFO_0004833
Disease	Familial aplasia of the vermis	OFD1 CEP290	2.69e-03	20	114	2	cv:C0431399
Disease	Prostatic Neoplasms	ITSN1 ITGB3 BRD4 ITSN2 TMOD1 PDS5A PRKDC ATM	2.74e-03	616	114	8	C0033578
Disease	Malignant neoplasm of prostate	ITSN1 ITGB3 BRD4 ITSN2 TMOD1 PDS5A PRKDC ATM	2.74e-03	616	114	8	C0376358
Disease	Stomach Carcinoma	POLE ATM	2.96e-03	21	114	2	C0699791
Disease	intellectual disability (implicated_via_orthology)	CUL4B ITSN1 ITSN2	3.10e-03	75	114	3	DOID:1059 (implicated_via_orthology)
Disease	Bronchiectasis	RSPH4A CCDC39	3.25e-03	22	114	2	C0006267
Disease	Glioblastoma	BRD2 BRD4 SEPTIN14	3.59e-03	79	114	3	C0017636
Disease	mean corpuscular hemoglobin concentration	CUL1 HDAC9 PDS5B SLC35D2 ITSN1 BRD3 OR10X1 ITPR2 BRD4 PRKDC TRAF3IP3	3.71e-03	1105	114	11	EFO_0004528
Disease	lung squamous cell carcinoma (is_implicated_in)	POLE ATM	3.86e-03	24	114	2	DOID:3907 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
NLMEVLKNAVKVVNF	FAM200B	341	P0CF97
AQALEKIFLQKVAQM	BRD3	126	Q15059
QLKSSLIMLQKTFDL	GRAMD1C	636	Q8IYS0
LIMLQKTFDLLNKNK	GRAMD1C	641	Q8IYS0
LKQEASFLKEQMILV	COG7	76	P83436
VFLRIKQQLLLISKM	COG7	586	P83436
KLQVIQFKLADMALA	ACADS	306	P16219
IVLMAEALEKLFLQK	BRD4	146	O60885
NMVIGILVFNKLVSK	ADGRB1	1106	O14514
LLSNFKTHLKMQIEV	ARFGEF1	511	Q9Y6D6
FQLKKQMLESVLLEL	GZF1	126	Q9H116
KILEILKLDQFLTLM	ABCA13	2306	Q86UQ4
ALVASEAKIQQLMKV	GIT2	436	Q14161
MATLNLFQIVSKHLK	CCDC42	261	Q96M95
MENAIKSVQIDLLKL	CAVIN4	61	Q5BKX8
ISQQTKLIDFLQAKM	CIT	1216	O14578
QMLLLETLKVKQTIL	ASTE1	441	Q2TB18
MNQKTILVLLILAVI	AOC3	1	Q16853
KQSLMTKINELNLFI	CCDC39	526	Q9UFE4
VELFKELSINVMKQL	GMCL1	246	Q96IK5
MASAKLNTLLQTKVI	NBEAL1	1591	Q6ZS30
KSLVATFIVKDLLMN	PDS5B	786	Q9NTI5
KVFFAVMLLQGIVQK	PGBD4	156	Q96DM1
KSVVANFIVKDLLMN	PDS5A	796	Q29RF7
EATNAVLMEQIKLLK	RGPD5	1676	Q99666
EATNAVLMEQIKLLK	RGPD8	1676	O14715
QQEFSIAMKLIKLKL	ITSN2	76	Q9NZM3
AKEKVFTMQDLLQLI	OFD1	101	O75665
VMDTKLKIIEILQFI	ITPR2	966	Q14571
LIVLNSLKKMANLTE	LRRC8A	581	Q8IWT6
SMLVQKLEDKISLLN	RELCH	356	Q9P260
VSMLKNEVAQLKQLL	CREB5	421	Q02930
LMENAAKETLVLKLN	PCDHA11	251	Q9Y5I1
QTMKINQTILKEFIL	OR10X1	16	Q8NGY0
IKELKLQTNHVTMLL	NEMF	396	O60524
LKLMQEKETGLNVFL	MALT1	446	Q9UDY8
QILKIAMVTIQLVLF	MCOLN3	66	Q8TDD5
AVLALVAIFIMSLNK	MFSD9	446	Q8NBP5
KVMENGLLFKELLQT	GPD1L	171	Q8N335
KEQIQINSAIEKFLM	LRRC53	601	A6NM62
MKLVSDLKQFLILND	MED22	76	Q15528
DDQVFLMKLQSLLAK	DYNC1LI1	371	Q9Y6G9
AILEKLMTLVSFKQN	FSIP2	826	Q5CZC0
VTDLKKAQINIVFDM	EFCAB9	56	A8MZ26
NENLSVLLMAKKFEI	ENOSF1	336	Q7L5Y1
VKKLDVLSNSLVINM	FBP2	71	O00757
ALLFMLNQKVKTLEV	PLVAP	156	Q9BX97
LKTKTIRQAMFQLLQ	OR51T1	296	Q8NGJ9
LKKIAATIISFMQVQ	PDE5A	351	O76074
LMIFKLVQARNKIIG	HRNR	76	Q86YZ3
KLLDTMVDTFLQKLV	PMF1	36	Q6P1K2
FVLISQLKEEVMSLK	FAM76B	246	Q5HYJ3
IILVNKLGQVFVKMA	KMT2B	2191	Q9UMN6
VLQKKLMAFTLQDLV	POLE	2206	Q07864
IQFVKLFGMVKIDNL	HNF4G	306	Q14541
IMEQLKSFQIIAHLK	IKBIP	106	Q70UQ0
NVMVKKQVFELLAAL	INF2	136	Q27J81
AVVLKSKMLFFLQLT	MED14	1356	O60244
MLVNQLAKDKTISVL	OR2T10	81	Q8NGZ9
LFLNKQDMLAEKVLA	GNAL	276	P38405
MNLLTAKDTKIILVI	KPNA2	426	P52292
QLTLMDAELFKKVVL	RGL4	226	Q8IZJ4
KLVVNLLQLSKMAIN	ATM	1646	Q13315
VFQASLKLLKMIITQ	CEP104	496	O60308
LAQVTFQVLSMKKEL	DNAH17	3731	Q9UFH2
MAIFKIAALQKVVDN	CEP290	941	O15078
INFSIKAKLDLVQSM	FCF1	76	Q9Y324
VLVANNSDTLKLLKM	FBXL3	191	Q9UKT7
IKMDILAQVLQILLK	CUL1	631	Q13616
VEFSIAMKLIKLKLQ	ITSN1	76	Q15811
LVQLAICKFEKTIML	IFIT1B	321	Q5T764
NAILMEQIKLLKSEI	GCC2	1586	Q8IWJ2
IILFLNKMDLLVEKV	GNA12	291	Q03113
IDLELFVNKMTATKL	INPP5B	736	P32019
KILKLIINELSNVME	IPO9	916	Q96P70
MTEKLSQKNINLIFA	ITGB3	321	P05106
QMSKELVELNKALAL	KIF4A	521	O95239
SLQKIIEIQSMSLKF	HDAC9	996	Q9UKV0
KELQVSLFQTLVLLM	CUL4B	741	Q13620
KNKAIIFMINLSVAD	P2RY10	66	O00398
VQNKKRQVAFFILLM	PCDHB6	6	Q9Y5E3
MNNFILLEEQLIKKS	ITK	1	Q08881
NLQRVTIKSMQLLFK	MROH2A	1286	A6NES4
AKLFMVAVKQELSQA	RTEL1	896	Q9NZ71
MLEITIQNAKAYLLK	RSPH4A	206	Q5TD94
AATIMILYVSKLNKI	SLC35D2	66	Q76EJ3
KMDFKTNILLKNLVT	TRIM43	61	Q96BQ3
FLTLKGSLKQRIQVM	SLC6A1	556	P30531
DLLTMKNLDSKVNII	SEPTIN14	176	Q6ZU15
ILKLLVQQFSILETM	TDO2	121	P48775
KLLQLKNFNTLMAVV	RASGRP3	231	Q8IV61
KLQLLAVVAFAVAML	HS2ST1	11	Q7LGA3
AMKKIEDNNTLVFIV	RPL23A	86	P62750
KQLQAIEFNKALLAM	SRP72	301	O76094
EILLTFKIKVMALNS	TBC1D7	241	Q9P0N9
MLALQIIDLFKNIFQ	PI4KAP2	346	A4QPH2
TLILQMNQLKELSKI	TLR1	376	Q15399
DLTSVNILLKKQQML	SPTBN1	1411	Q01082
MNTLFTLLKVDTQIK	ABCB7	441	O75027
AQTLEKIFLQKVASM	BRD2	166	P25440
LEKKMAVASILQSLQ	AFAP1L1	31	Q8TED9
ALLKVAQMVTLLIAF	CMTM7	46	Q96FZ5
MTKEFIGQQLILIIK	NCAPG	396	Q9BPX3
TIKISALKAIFDQLM	NCAPG	636	Q9BPX3
EVAMLLDTVQKVFQK	NCAPG2	946	Q86XI2
LLMELKVAAQKNFIL	C12orf56	351	Q8IXR9
LKQKMVILQDLLSTL	TRAF3IP3	211	Q9Y228
QLSFKIIQTDLTMLK	TLK1	206	Q9UKI8
LTMLKLAALESNKIQ	TLK1	216	Q9UKI8
KELQNFLSMFQKIIL	WASHC5	886	Q12768
EIVSMLEKNATLLKF	TMOD1	301	P28289
FKMLSNKESLDQIIV	UBL7	131	Q96S82
LELSSNKTFFIMLKI	TTMP	101	Q5BVD1
LQIMESQAEAFLKKL	TTC3	1656	P53804
LLNFEIKEVVVTLMK	VPS13C	1426	Q709C8
IIKEDVNSMQIFTKL	SUCO	806	Q9UBS9
TFLDKILVKLKMQLN	PLCB2	146	Q00722
TKMAVLALLAKILQI	PRKDC	1641	P78527
DFLHKMTVVVLQKLN	ZNF644	831	Q9H582
KMDFKTNILLKNLVT	TRIM43B	61	A6NCK2
LLKQMVSFEKVKLTN	TBX20	196	Q9UMR3
FEKLKQTLEMNLTNL	MID2	236	Q9UJV3
VFVLNANLLSMVKIV	ZFYVE9	941	O95405
KKFVQMLVFNLTLTE	UGT2A2	11	P0DTE5
QRVQKEQLAAIFKLM	MXRA7	166	P84157